Results 41 to 50 of about 491 (150)
Correction: The potential of undenatured type II collagen against arthritis: a review
Collagen and LeatherYuhao Zhou +4 more
doaj +2 more sources
Protein‐based Nanoparticles: From Drug Delivery to Imaging, Nanocatalysis and Protein Therapy
Angewandte Chemie International Edition, Volume 62, Issue 44, October 26, 2023., 2023 In the last decade, significant progress was made in the development of protein nanoparticles, transitioning from artificial assemblies for drug delivery, to multifunctional systems for nanocatalysis and protein therapy. Advanced biohybrid materials, combined with dynamic chemistries and mild methods of particle formation produce nanoparticles that ...
Jonas Kaltbeitzel, Peter R. Wich
wiley +1 more source
Food Science &Nutrition, Volume 11, Issue 6, Page 2547-2579, June 2023., 2023 Therapeutics properties of animal milk components against pathogenic viruses such as COVID‐19. Abstract The global pandemic of COVID‐19 is considered one of the most catastrophic events on earth. During the pandemic, food ingredients may play crucial roles in preventing infectious diseases and sustaining people's general health and well‐being.
Parminder Singh +2 more
wiley +1 more source
Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers. [PDF]
J Int Soc Sports Nutr, 2013 Background UC-II contains a patented form of undenatured type II collagen derived from chicken sternum. Previous preclinical and clinical studies support the safety and efficacy of UC-II in modulating joint discomfort in osteoarthritis and rheumatoid ...
Lugo JP +6 more
europepmc +2 more sources
Tissue adhesives for wound closure
Smart Medicine, Volume 2, Issue 1, February 2023., 2023 In this paper, we present an up‐to‐date review of tissue adhesives for wound closure. We mainly discussed the fundamental design requirements for the adhesives, the fabrication of tissue adhesives, and the application of tissue adhesives on skin healing, corneal patch, and gastrointestinal tissues.
Bin Kong +4 more
wiley +1 more source
[Retracted] Healthcare and Scientific Treatment of Knee Osteoarthritis
Journal of Healthcare Engineering, Volume 2022, Issue 1, 2022., 2022 Knee osteoarthritis is a chronic degenerative disease companied with chronic knee pain and dysfunction. However, the etiology and pathogenesis of knee osteoarthritis were unclear. Currently, age, diet, trauma, obesity, and inheritance are the main risk factors. The major pathological hallmarks of knee osteoarthritis included subchondral bone sclerosis,
Huan Wang, Baoan Ma, Rahim Khan
wiley +1 more source
FASEB BioAdvances, Volume 3, Issue 4, Page 243-258, April 2021., 2021 Abstract Moyamoya disease (MMD) is a cryptogenic vascular disorder in the intracranial arteries. RING protein 213 (RNF213) is the susceptibility gene for MMD, and encodes a RING domain and a Walker motif. Herein, we identified UBC13 (UBE2N) as an E2 ubiquitin‐conjugating enzyme for RNF213 E3 ubiquitin ligase by yeast two‐hybrid screening with a ...
Toshiyuki Habu, Kouji H. Harada
wiley +1 more source
Неврология, нейропсихиатрия, психосоматика, 2022 Backpain and pain in the limbs are often associate with the destruction of the cartilage and bone tissue of the joint, which affects the nerve terminals and leads to an exacerbation of pain symptoms (as happens, for example, in osteoarthritis).
O. A. Gromova, I. Y. Torshin, A. M. Lila
doaj +1 more source
Медицинский совет, 2022 Among the proteins of the human body, collagen accounts for at least 25–45% collagen; it is an essential structural component of skeletal tissues, connective tissue of internal organs (heart, intestines, lungs, liver, kidneys), as well as blood vessels ...
I. S. Dydykina +3 more
doaj +1 more source
, 2023 Osteoarthritis (OA) is the most common cause of pain and disability in adults. Dietary supplements such as undenatured type II collagen (UC-II) have shown to have some benefits in OA treatment. This study aimed to assess changes in pain levels among knee OA patients treated with UC-II for 6 months.
Tomás Fernando Fernández-Jaén +7 more
openaire +1 more source